Commission hosts event on COVID-19 therapeutics

On July 12 and 13, the Commission is hosting a new pan-European matchmaking event to accelerate and upscale the development and production of COVID-19 therapeutics in the EU. With the spread of variants and the resurgence of cases across the EU in recent weeks, the development of therapeutics is more necessary than ever, the Commission said.

The matchmaking event, a step in implementing the Commission’s strategy on COVID-19 therapeutics  adopted in May 2021, aims at enhancing the participation of companies in EU value chains for COVID-19 therapeutics, speed up connection between organisations and companies and help in production planning.

“The EU is making good progress on vaccination with 50% of adults now fully vaccinated. But vaccines are not our only response to COVID-19″, said Health Commissioner Stella Kyriakides.

“I am encouraging companies to step forward and join forces to develop and produce COVID-19 therapeutics in the EU. Through our EU Therapeutics Strategy, we have already identified the first five most promising therapeutics with the target to authorise three new treatments by October 2021. With the support of events such as the one today, we may soon have many more”, added Kyriakides.